Skip to content
New: 100+ more US companies, including the big banks, plus insider trades from SEC filings

Health Care · NYSE: CNC

Centene: how the business works

Centene runs health plans, mostly paid for by governments, for 27.6 million members, with total revenues of $194.8 billion in FY2025.

By · Checked against filings: . Editorial policy. Corrections

Follow Centene

Email me when Centene's page is updated after earnings.

We'll send a confirmation email first. See our privacy policy.

Centene Corporation · St. Louis, Missouri · Founded 1984

Updated for Q3 FY2026 · checked

Total revenues, FY2025
$194.8B
Net loss, FY2025
$6.67B
Members, Dec 31, 2025
27.6 million
Health benefits ratio, FY2025
91.9%
Employees, Sep 30, 2026
53,900

For learning only. Cityfort is not a registered investment adviser or broker-dealer and does not recommend buying or selling any security. Prices shown are dated and may be out of date.

The short version

Centene in 5 points

  1. 1 · What it sells

    Centene runs Medicaid, Medicare and Marketplace health plans for 27.6 million members at Dec 31, 2025, with total revenues of $194.8 billion in FY2025.

    More: what it sells

  2. 2 · Who pays it

    In FY2025, Centene's Medicaid segment, paid by states, brought in 57% of external revenues, Commercial (mostly Marketplace plans) 21%, Medicare 19% and Other 3%.

    More: who pays it

  3. 3 · What it keeps from $100

    Of every $100 that came in during FY2025, Centene spent $80.32 on medical bills and lost $3.40 after $7,311 million of impairment charges; adjusted net earnings, a non-GAAPThe company's own "adjusted" numbers, not the official (GAAP) ones. Always read them next to the official figure. Learn more measure, were $1,028 million.

    More: what it keeps from $100

  4. 4 · Where the operating profit comes from

    FY2025 gross margin (premium and service revenues less medical and service costs) was $5,690 million in Medicaid, $5,101 million in Commercial, $2,983 million in Medicare and $435 million in Other.

    More: where the operating profit comes from

  5. 5 · The one thing to watch

    The health benefits ratio was 92.7% in Q3 FY2026; on Oct 27, 2026, Centene said it expects 90.4% to 91.1% for full-year 2026.

    More: the one thing to watch

Sources: From Centene's FY2025 10-K and its Q3 FY2026 earnings release · checked

01Where $100 of an insurer's money goes · FY2025

Where does $100 of Centene's money go?

Of every $100 that came in (premiums earned plus investment income, fees and other income), this is where it went, starting with claims.

Centene · FY2025

Receipt for every $100

Where $100 of Centene's money went in FY2025
Members' medical bills (medical costs)$80.3
Premium taxes paid to states$10.5
Running costs (SG&A and cost of services)$7.9
Impairment charges (mostly goodwill)$3.7
Depreciation, amortization and interest$1.0
Income tax (a benefit)−$0.0
Net loss−$3.4
Total$100

Each line = amount ÷ total money in × 100. Lines may not add to exactly $100 because of rounding.

How this is worked out

Cityfort calculation from the FY2025 10-K: each line ÷ $196,349 million of money in (total revenues of $194,777 million plus $1,572 million of investment and other income) × 100. The net loss line includes $7,311 million of impairment charges.

Save this receipt as an image

Embed this receipt or the key numbers

Paste this code into a blog or website to show the card you choose, with a link back to this page.

Each week: the next company due to report earnings, explained in 5 points.

No tips. Unsubscribe anytime.

We'll send a confirmation email. See our privacy policy.

02The business in one line

What does Centene do?

States, the federal government and members pay Centene premiums; members' medical bills took 91.9% of those premiums in FY2025.

  • Centene's Medicaid segment, paid by states, brought in 57% of external revenues in FY2025, Commercial 21% and Medicare 19%.
  • Of every $100 that came in during FY2025, medical bills took $80.32 and premium taxes $10.46; impairment charges turned the year into a $3.40 loss.

03Who pays it

Who pays Centene?

  • State Medicaid agencies

    57%

    of revenue

    States pay a monthly premium per Medicaid member under multi-year contracts that are re-bid.

  • Marketplace members and federal subsidies

    21%

    of revenue

    Individuals buy Ambetter Health plans; the federal government pays part of many premiums through tax credits.

  • Medicare program and its members

    19%

    of revenue

    The federal Centers for Medicare and Medicaid Services (CMS) pays for Medicare Advantage and drug plans, with members paying part of some premiums.

  • Other customers

    3%

    of revenue

    Payers for specialty pharmacy, behavioral health, vision and dental services.

  • State Medicaid agencies57%
  • Marketplace members and federal subsidies21%
  • Medicare program and its members19%
  • Other customers3%

How spread out the customers are

No single customer was more than 10% of Centene's total revenues in 2023, 2024 or 2025. Most revenue comes from state Medicaid contracts, and Florida and New York were each about 10% or more of Medicaid premium revenues in 2025.

04How it makes money

How does Centene make money?

Centene earns the gap between the premiums it collects and the medical bills it pays.

Premiums are set before the year starts, and members' bills come in later. Medical costs took 87.8% of premiums in FY2021 and 91.9% in FY2025, so a few points decide whether the year makes money.

Health benefits ratio (medical costs ÷ premiums)

87.8%91.9%

FY2021 to FY2025

  1. States, the federal government and members pay a premium for each member.
  2. Centene pays doctors, hospitals and pharmacies for members' care.
  3. Selling and administrative costs were 7.4% of premium and service revenues in FY2025 (Centene's SG&A expense ratio).
  4. Money waiting to pay claims is invested and earns income.
  5. Prices and benefits are reset for the next year, based on how costs ran.

↺ Step 5 feeds back into step 1.

05Business segments · FY2025

Which businesses make up Centene?

  • Medicaid

    56.7%

    State Medicaid plans. Gross margin (premium and service revenues less medical and service costs) was $5,690 million in FY2025.

    Revenue $110.4B ($110,434M)

  • Commercial

    21.6%

    Marketplace and other individual and group plans. Gross margin was $5,101 million in FY2025, down from $7,663 million in FY2024.

    Revenue $42.0B ($42,003M)

  • Medicare

    19.1%

    Medicare Advantage, drug plans and Medicare Supplement. Gross margin was $2,983 million in FY2025.

    Revenue $37.2B ($37,210M)

  • Other

    2.6%

    Specialty pharmacy, behavioral health, vision, dental and primary care. Gross margin was $435 million in FY2025.

    Revenue $5.1B ($5,130M)

How the mix changed

  • Medicaid
  • Commercial
  • Medicare
  • Other

Revenue by segment, FY2022 to FY2025.

US$

See the numbers
How the mix changed (US$)
YearMedicaidCommercialMedicareOther
FY2022$93.2B$17.4B$22.5B$11.5B
FY2023$100.8B$24.8B$22.3B$6.1B
FY2024$101.4B$33.7B$23.0B$4.9B
FY2025$110.4B$42.0B$37.2B$5.1B

06The numbers · Consolidated · US$

How has Centene done?

Premiums

$171.6BFY2025

Premium revenue rose every year, from $112,319 million in FY2021 to $171,556 million in FY2025, and was $44,370 million in Q3 FY2026, up from $44,126 million a year earlier.

US$ · premiums from policyholders and plan members, as reported

See the yearly numbers
Premiums by year, US$
YearPremiums
FY2021$112.3B
FY2022$127.1B
FY2023$135.6B
FY2024$142.3B
FY2025$171.6B
See the quarterly numbers
Premiums by quarter, US$
QuarterPremiums
Q1 FY2024$35.5B
Q2 FY2024$35.1B
Q3 FY2024$36.1B
Q4 FY2024$35.5B
Q1 FY2025$41.7B
Q2 FY2025$41.7B
Q3 FY2025$44.1B
Q4 FY2025$44.0B
Q1 FY2026$43.9B
Q2 FY2026$43.6B
Q3 FY2026$44.4B

Medical care ratio

91.9%FY2025

The health benefits ratio, the share of premiums spent on members' medical care, was 87.7% to 87.8% from FY2021 to FY2023, rose to 91.9% in FY2025 and was 92.7% in Q3 FY2026.

Centene calls its medical care ratio the health benefits ratio (HBR): medical costs ÷ premium revenue, leaving out service revenue and premium tax revenue.

% of premiums · medical costs per $100 of premiums, as reported

See the yearly numbers
Medical costs, premiums and the medical care ratio by year, US$ and %
YearMedical costsPremiumsMedical care ratio
FY2021$98.6B$112.3B87.8%
FY2022$111.5B$127.1B87.7%
FY2023$118.9B$135.6B87.7%
FY2024$125.7B$142.3B88.3%
FY2025$157.7B$171.6B91.9%
See the quarterly numbers
Medical care ratio by quarter, %
QuarterMedical care ratio
Q1 FY202487.1%
Q2 FY202487.6%
Q3 FY202489.2%
Q4 FY202489.6%
Q1 FY202587.5%
Q2 FY202593.0%
Q3 FY202592.7%
Q4 FY202594.3%
Q1 FY202687.3%
Q2 FY202689.6%
Q3 FY202692.7%

Net income

−$6.7BFY2025

Net income was $3,305 million in FY2024 and a $6,674 million loss in FY2025, which included $7,311 million of impairment charges; investment and other income was $1,572 million in FY2025.

US$ · after claims, costs, investment results and tax; the table shows where it came from

See the numbers
Underwriting income, investment income, gains and net income by year, US$
YearUnderwriting incomeNet investment incomeRealized gains (losses)Unrealized gains (losses) in incomeNet income
FY2021–$819M––$1.3B
FY2022–$1.3B––$1.2B
FY2023–$1.4B––$2.7B
FY2024–$1.8B––$3.3B
FY2025–$1.6B––−$6.7B
See all yearly numbers
Centene insurance numbers, FY2021–FY2025, US$
YearPremiumsMedical costsOperating costsNet investment incomeNet incomeBook value per share ($)Return on equityEPS ($)
FY2021$112.3B$98.6B$9.6B$819M$1.3B––$2.28
FY2022$127.1B$111.5B$11.6B$1.3B$1.2B––$2.07
FY2023$135.6B$118.9B$12.6B$1.4B$2.7B––$4.95
FY2024$142.3B$125.7B$12.4B$1.8B$3.3B––$6.31
FY2025$171.6B$157.7B$12.9B$1.6B−$6.7B––−$13.53

Medical care ratio = medical costs ÷ premiums, as the company reports it. Net investment income is interest and dividends on the money the company holds before paying claims; realized and unrealized gains are shown apart because they move with markets. Net income is the amount for common stockholders. Fiscal years are the company's own (December 31. Centene's fiscal year matches the calendar year: FY2025 ended Dec 31, 2025, and Q3 FY2026 ended Sep 30, 2026.).

  • Revenue on this page is Centene's total revenues, which include state premium taxes it collects and pays on ($20,196 million in FY2025); premium and service revenues were $174,581 million.
  • Fees and other is service revenue plus premium tax revenue. Investment income sits in one line with other income, below total revenues in Centene's statements, so premiums, fees and investment income add up to about 1% more than total revenues. Centene reports no separate realized or unrealized gains lines.
  • Members are total members at year end, as reported; up to FY2024 they include 2.7 million to 2.9 million TRICARE military health eligibles, under a contract that ended in December 2024. In 2026 Centene moved some members eligible for both Medicaid and Medicare from its Medicaid to its Medicare tables.
  • Underwriting expenses are selling, general and administrative expenses (SG&A). Book value per share and return on equity are not shown because Centene does not report them.

Learn: How to read a US earnings release: Nvidia's Q2 fiscal 2027 · What is return on equity? Profit on equity, with real US companies

07Who runs it

Who runs Centene, and did they deliver?

  • Sarah M. London

    Chief Executive Officer · since 2022

    CEO since March 2022.

  • Andrew L. Asher

    Executive Vice President and Chief Financial Officer · since 2021

    CFO since May 2021; earlier CFO of WellCare from 2014 to 2020.

  • Susan R. Smith

    Chief Operating Officer

  • Frederick H. Eppinger

    Independent Chairman of the board · since 2006

    Director since 2006; the chair has been separate from the CEO since Mar 22, 2022.

What they said, and what happened

1 too early to tell · 1 delivered

  1. Said on Feb 6, 2026

    Full-year 2026 adjusted diluted EPS (a non-GAAP measure) above $3.00.

    What happened

    Centene raised it to above $3.40 on Apr 28, above $4.80 on Jul 28 and above $5.20 on Oct 27, 2026; adjusted diluted EPS was $6.45 for the first nine months.

    Too early to tell
  2. Said on Oct 8, 2026

    Redeem the remaining 4.25% senior notes due 2027 on Oct 23, 2026.

    What happened

    The Q3 FY2026 earnings release says the 2027 notes were fully redeemed in October.

    Delivered

08What could go wrong

What could go wrong for Centene?

  • Pricing

    Medical costs above what was priced

    Centene sets premiums before the year starts. Medical costs took 87.7% of premiums in FY2023, 91.9% in FY2025 and 92.7% in Q3 FY2026.

    Watch The health benefits ratio each quarter, against the 90.4% to 91.1% range Centene gave for 2026 on Oct 27, 2026.

  • Regulation

    Changes to government health programs

    Extra federal Marketplace subsidies ended after 2025. A July 2025 federal law adds Medicaid work requirements and more frequent eligibility checks, largely from 2027. Marketplace members fell from 5.54 million at Dec 31, 2025 to 3.40 million at Sep 30, 2026.

    Watch Marketplace and Medicaid membership each quarter.

  • Concentration

    Losing or re-bidding state contracts

    Most revenue comes from state Medicaid contracts that are re-bid, and Florida and New York were each about 10% or more of Medicaid premium revenues in 2025. From Jan 1, 2027, about 175,000 Health Net members in California move to fee-for-service Medi-Cal.

    Watch State contract awards, renewals and losses in 8-Ks and earnings releases.

  • Regulation

    Risk-adjustment estimates

    Marketplace insurers pay into or receive from a federal risk-adjustment pool, settled after the year ends. In June 2026, CMS's final 2025 figures cut Centene's net payable by $541 million.

    Watch Changes to risk-adjustment estimates in each 10-Q.

  • Legal

    Shareholder lawsuits

    The Q3 FY2026 10-Q says a proposed class action filed on Jul 9, 2025 alleges false and misleading statements about Centene's 2025 earnings guidance, and five derivative suits followed. Centene denies wrongdoing; the 10-Q says an adverse outcome could have a material impact.

    Watch Court rulings or settlements disclosed in 10-Qs.

  • Debt

    Debt and cash held in regulated units

    Total debt was $15,542 million at Sep 30, 2026. Most cash sits in state-regulated subsidiaries; $175 million was available for general corporate use.

    Watch Debt to capitalization (41.1% at Sep 30, 2026) and dividends from subsidiaries to the parent.

09Supporters vs. critics

What do supporters and critics point to?

Facts each side points to. We don't say which side is right.

What supporters point to

  • Centene says it is the largest Medicaid and Marketplace insurer and the largest stand-alone Medicare drug plan provider by membership.
  • Net income was $1,541 million in Q1 FY2026 and $1,091 million in Q2 FY2026, after losses in the last three quarters of FY2025.
  • Medicare drug plan members grew from 6.93 million at Dec 31, 2024 to 8.95 million at Sep 30, 2026.
  • Centene raised its 2026 adjusted diluted EPS guidance (a non-GAAP measure) three times, from above $3.00 on Feb 6 to above $5.20 on Oct 27, 2026.
  • Centene says its regulated subsidiaries had $19.7 billion of statutory capital and surplus at Dec 31, 2025, against an $11.3 billion minimum.

What critics point to

  • Medical costs took 87.7% of premiums in FY2023, 91.9% in FY2025 and 92.7% in Q3 FY2026.
  • FY2025 ended with a $6,674 million net loss, which included $7,311 million of impairment charges.
  • Marketplace members fell from 5.54 million at Dec 31, 2025 to 3.40 million at Sep 30, 2026.
  • A proposed securities class action filed on Jul 9, 2025 alleges that Centene made false and misleading statements, and five derivative suits followed; Centene denies wrongdoing.
  • Total debt was $15,542 million at Sep 30, 2026, and $175 million of cash was available for general corporate use.

10What to watch next

What should you watch next at Centene?

Next event

Q4 and full-year FY2026 results

Date not announced yet.

  • The health benefits ratio

    It was 92.7% in Q3 FY2026. On Oct 27, 2026, Centene said it expects 90.4% to 91.1% for full-year 2026.

  • FY2026 results against guidance

    On Oct 27, 2026, Centene said it expects 2026 GAAP diluted EPS above $3.46 and adjusted diluted EPS, a non-GAAP measure, above $5.20.

  • Marketplace and Medicaid members

    Marketplace had 3.40 million members and Medicaid 11.90 million at Sep 30, 2026, both lower than at Dec 31, 2025.

  • Contracts and lawsuits

    About 175,000 California Health Net members move to fee-for-service Medi-Cal from Jan 1, 2027. The shareholder suits are updated in each 10-Q.

11Key facts

Key facts about Centene

What does Centene do?
Centene Corporation, based in St. Louis, Missouri, runs health plans mostly paid for by governments. It runs Medicaid plans in 30 states, Medicare Advantage and drug plans, and Ambetter Health plans on the Affordable Care Act Marketplace. Centene had 27.6 million members at Dec 31, 2025.
How does Centene make money?
Centene collects a premium for each member and pays doctors, hospitals and pharmacies for the members' care. In FY2025, medical costs took 91.9% of Centene's $171,556 million of premium revenue, and selling and administrative costs were 7.4% of premium and service revenues (Centene's SG&A expense ratio).
Who are Centene's customers?
Centene's Medicaid segment, paid by state Medicaid agencies, brought in 57% of its external revenues in FY2025. Commercial, mostly Marketplace plans, brought in 21%, Medicare 19% and Other 3%. No single customer was more than 10% of Centene's total revenues in 2023, 2024 or 2025.
How big is Centene?
Centene had total revenues of $194,777 million in FY2025, up from $163,071 million in FY2024. Centene reported net income of $3,305 million in FY2024 and a net loss of $6,674 million in FY2025, which included $7,311 million of impairment charges.
Why did Centene lose money in FY2025?
Centene's FY2025 net loss of $6,674 million included $7,311 million of impairment charges, mostly a $6,723 million goodwill impairment. Goodwill is the amount paid for past acquisitions above the value of their assets. Medical costs also took 91.9% of premiums in FY2025, up from 88.3% in FY2024. Centene's adjusted net earnings, a non-GAAP measure that leaves out these charges, were $1,028 million in FY2025.
How did Centene do in Q3 FY2026?
Centene had total revenues of $50,647 million in Q3 FY2026 and a net loss of $71 million, against a $6,631 million loss in Q3 FY2025. Its health benefits ratio, medical costs as a share of premiums, was 92.7% in both quarters.
How many members does Centene have?
Centene's Marketplace members fell from 5.54 million at Dec 31, 2025 to 3.40 million at Sep 30, 2026. Its Medicaid members fell from 12.52 million to 11.90 million, and its Medicare drug plan members reached 8.95 million over the same period.
Who runs Centene?
Sarah London has been Centene's chief executive officer since March 2022, and Andrew Asher its chief financial officer since May 2021. Frederick Eppinger, a director since 2006, is Centene's independent chairman.
Who owns Centene?
Centene has one class of common stock, with 494.97 million shares outstanding at Sep 30, 2026. The 2026 proxy lists The Vanguard Group at 12.4%, BlackRock at 7.8% and AQR Capital Management at 6.5%, from filings of different dates. Centene's directors and executive officers together owned under 1% as of Mar 13, 2026.

Terms on this page

Each explains the term in plain English, with the same number from other companies on Cityfort.

Go deeper

More detail from the same filings. Open any section.

12What it sells

12What it sells

What does Centene sell?

Centene runs health plans that governments mostly pay for. States hire it to run Medicaid, the health program for people with low incomes. It also sells Medicare plans for people 65 and over, and individual plans on the Affordable Care Act Marketplace.
  • Medicaid plans

    Health coverage that states pay Centene to manage, including care for children, pregnant women, disabled adults and long-term care. 12.5 million members in 30 states at Dec 31, 2025.

  • Medicare Advantage (Wellcare)

    Private plans that replace traditional Medicare for people 65 and over, including plans for people who also qualify for Medicaid. 1.0 million members in 32 states at Dec 31, 2025.

  • Medicare drug plans

    Stand-alone prescription drug plans (PDP) for Medicare members, sold in all 50 states and DC. 8.1 million members at Dec 31, 2025.

  • Marketplace plans (Ambetter Health)

    Individual health insurance bought on the Affordable Care Act exchanges, often with federal subsidies. 5.5 million members in 29 states at Dec 31, 2025.

  • Other services

    A specialty pharmacy (AcariaHealth), vision and dental services, primary care centers in Florida and the Magellan Health behavioral health business, which Centene agreed to sell in December 2025.

What it does

  • Does: Collects a monthly premium for each member from states, the federal government or the member
  • Does: Pays doctors, hospitals and pharmacies for members' care
  • Does: Collects state premium taxes and passes them on

What it does not do

  • Does not: Does not run most of the hospitals and doctor offices its members use; it signs contracts with them
  • Does not: Does not run its own pharmacy benefit manager; it has used an outside one since January 2024
  • Does not: Has few employer plan members: individual and commercial group plans had 452,500 members at Dec 31, 2025
13How the money flows

13How the money flows · FY2025

How does money flow through Centene?

Money in

  • Premiums$171.6B
  • Service revenue$3.0B
  • Premium tax revenue (collected for states)$20.2B
  • Investment and other income$1.6B

The company

Centene

$196.3B came in

Money out

  • Members' medical bills (medical costs)$157.7B
  • Premium taxes paid to states$20.5B
  • Running costs (SG&A and cost of services)$15.6B
  • Impairment charges (mostly goodwill)$7.3B
  • Depreciation, amortization and interest$2.0B
  • Income tax (a benefit)−$51M
  • Net loss attributable to Centene−$6.7B
  1. States, the federal government and members paid $171,556 million of premiums in FY2025, and services added $3,025 million.
  2. Centene also collected $20,196 million of state premium taxes, and its investments earned $1,572 million.
  3. Members' medical bills took $157,702 million, or 91.9% of premiums.
  4. Running costs took $15,574 million, and premium taxes paid to states were $20,538 million.
  5. Impairment charges of $7,311 million left a $6,674 million net loss for the year.
14What it needs to run

14What it needs to run

What does Centene need to run?

  • Doctor and hospital networks

    Centene pays providers per service, a fixed monthly amount per member (capitation) or under value-based contracts that share savings or risk.

  • Government contracts

    State Medicaid contracts run for set terms and are re-bid; in 2024 and 2025 Centene started new or renewed contracts in Florida, Kansas, Michigan, Texas and other states.

  • Capital in regulated health plans

    State rules set minimum capital for its regulated health plans: they had $19.7 billion of statutory capital and surplus at Dec 31, 2025, against an $11.3 billion minimum.

  • Staff

    About 61,100 employees at Dec 31, 2025 and 53,900 at Sep 30, 2026.

15Where growth could come from

15Where growth could come from

Where could Centene's growth come from?

On Oct 27, 2026, Centene said it expects 2026 GAAP diluted earnings per share (EPS) above $3.46 and adjusted diluted EPS (a non-GAAP measure) above $5.20. On Feb 6, 2026, it had said above $1.98 and above $3.00. It expects total revenues of $196.5 billion to $200.5 billion and a health benefits ratio of 90.4% to 91.1%.
Management statement, Oct 27, 2026. Reported as a statement, not our forecast.
  • Medicare drug plans

    Working

    8.95M members, Sep 30, 2026

    Stand-alone drug plan members grew from 6.93 million at Dec 31, 2024 to 8.95 million at Sep 30, 2026. Centene said its Q3 FY2026 health benefits ratio was better than it expected, led by the Medicare segment.

    Status: Working, on track against what the company said.

  • Marketplace repricing

    Mixed

    3.40M members, Sep 30, 2026

    The 2026 proxy says Centene repriced 2026 Marketplace plans in states covering 95% of those members. Members fell from 5.54 million at Dec 31, 2025 to 3.40 million at Sep 30, 2026, and the Commercial health benefits ratio was 80.9% in the first nine months of 2026, against 85.3% a year earlier.

    Status: Mixed, partly on track.

  • Medicaid margins

    Mixed

    93.6% Medicaid HBR, Q3 FY2026

    Medicaid members fell from 12.52 million at Dec 31, 2025 to 11.90 million at Sep 30, 2026. The Medicaid health benefits ratio was 93.6% in Q3 FY2026, against 93.4% a year earlier; Centene said Medicaid was on track.

    Status: Mixed, partly on track.

  • Cost cuts

    New

    53,900 employees, Sep 30, 2026

    Centene started a voluntary separation program in July 2026. Employees fell from 61,100 at Dec 31, 2025 to 53,900 at Sep 30, 2026, and severance and outside vendor costs for these efforts were $297 million in Q3 FY2026.

    Status: New, recently announced.

Status compares progress with what the company itself said it would do: Working = on track against what the company said; Mixed = partly on track; Behind = behind the company's own plan; New = recently announced; Early = too early to judge.

16The company's own measures (non-GAAP)

16The company's own measures · FY2024, FY2025 and the first nine months of 2026

What do Centene's own measures show?

Adjusted (non-GAAP) figures are Centene's own measures, shown next to the official (GAAP) number and never added together. Centene leaves out amortization of acquired intangibles, acquisition and divestiture costs and other items such as impairments.
  • Official (GAAP): Diluted EPS, FY2025

    −$13.53

    Company's own measure: Adjusted diluted EPS, FY2025

    $2.08

    Centene adds back $6,723 million of goodwill impairment, a $513 million Magellan Health impairment and $685 million of amortization of acquired intangibles, among other items, less tax effects.

  • Official (GAAP): Net earnings (loss) attributable to Centene, FY2025

    −$6.7B

    Company's own measure: Adjusted net earnings, FY2025

    $1.0B

    Same adjustments: $7,328 million of other adjustments, $685 million of amortization and $4 million of acquisition and divestiture costs, less $315 million of tax effects.

  • Official (GAAP): Diluted EPS, FY2024

    $6.31

    Company's own measure: Adjusted diluted EPS, FY2024

    $7.17

    Mostly amortization of acquired intangibles ($692 million before tax) and acquisition and divestiture costs.

  • Official (GAAP): Diluted EPS, nine months to Sep 30, 2026

    $5.15

    Company's own measure: Adjusted diluted EPS, nine months to Sep 30, 2026

    $6.45

    Adjusted net earnings were $3,210 million in these nine months, against $1,611 million a year earlier.

These are the company's own measures, defined by the company. They are not comparable across companies, and they are not added together. Each sits beside the nearest official (GAAP) figure.

Learn: Non-GAAP measures: what a company's "adjusted" numbers leave out

17Financial strength: investments, debt, capital

17Financial strength · Sep 30, 2026

How strong is Centene's balance sheet?

Cash and investments were $39,850 million at Sep 30, 2026, and debt was 41.1% of total capitalization as Centene reports it.

What the premiums are invested in

  • Cash and cash equivalents$20.7B

    51.9% of the investments listed

  • Long-term investments$14.8B

    37.1% of the investments listed

  • Short-term investments$2.9B

    7.2% of the investments listed

  • Restricted deposits$1.5B

    3.7% of the investments listed

Shares of the portfolio: Cityfort calculation from the FY2025 10-K, each type ÷ the total listed.

Investments
$39.9B
money held in bonds, stocks and cash until claims are paid
Debt
$15.5B
borrowings on the balance sheet
Shareholders' equity
$22.2B
what the company owns minus what it owes
Debt to capital
41.1%
debt ÷ (debt + equity), as reported by the company
Members
27.6 million
people covered at the end of FY2025, as reported

Centene says its state-regulated subsidiaries had $19.7 billion of statutory capital and surplus at Dec 31, 2025, against an $11.3 billion minimum. Of the $39,850 million of cash and investments at Sep 30, 2026, $38,425 million sat in regulated subsidiaries, and $175 million of cash was available for general corporate use.

Figures at Sep 30, 2026, consolidated, as reported by the company in its 10-K and earnings release; see the dates on each source.

Learn: How to read a 10-K in 10 minutes

18Who owns it

18Who owns it · ownership as of Mar 13, 2026

Who owns Centene?

Centene's common stock carries one vote per share. Its 14 directors and executive officers together owned 1,823,921 shares, under 1%, as of Mar 13, 2026 (2026 proxy). Holder rows come from filings of different dates and are never added together.
Share classes
Centene share classes: shares outstanding (millions) and votes per share
ClassShares (millions)Votes per shareHeld by% of shares% of votesTraded
Common stock (494,973 thousand shares outstanding at Sep 30, 2026 (Q3 FY2026 10-Q).)4951Public, funds and insiders100.0%100.0%Yes
Holders of 5% or more
Centene holders of 5% or more, from the proxy statement or later Schedule 13G filings; each row shows its own date
HolderSharesVotesAs ofSourceNote
The Vanguard Group12.4%–Feb 13, 2024S3161,190,588 shares, from a Schedule 13G/A filed Feb 13, 2024, as listed in the 2026 proxy.
BlackRock, Inc.7.8%–Jul 16, 2025S3138,215,413 shares, from a Schedule 13G/A filed Jul 16, 2025, as listed in the 2026 proxy.
AQR Capital Management6.5%–Mar 13, 2026S3131,798,738 shares, as listed in the 2026 proxy.

From the company's proxy statement (DEF 14A), later Schedule 13G filings and the share counts on its latest annual or quarterly report. Each holder row shows the date of its own filing.

Learn: How to read a proxy statement (DEF 14A): Nvidia's 2026 proxy · Form 4 insider filings: who files, the codes and the footnotes

19What it does with profit

19What it does with profit

What does Centene do with its profit?

Centene's board has authorized $10.0 billion of buybacks in total, with $1.8 billion left at Dec 31, 2025. Buybacks fell from $2,999 million in FY2024 to $400 million in FY2025.
  • Buyback · Dec 31, 2023

    FY2023: bought back 22.9 million shares for $1,577 million.

    $1.6B

  • Buyback · Dec 31, 2024

    FY2024: bought back 42.0 million shares for $2,999 million.

    $3.0B

  • Buyback · Dec 31, 2025

    FY2025: bought back 6.7 million shares for $400 million.

    $400M

  • Buyback · Sep 30, 2026

    First nine months of 2026: paid $57 million for its own shares.

    $57M

20Governance signals

20Governance signals

What do Centene's governance filings show?

Auditor
KPMG LLP, since 2005
Auditor changes
None in the period covered
Audit qualifications
None reported
Related-party dealings
The 2026 proxy describes a written policy under which the board's Governance Committee must approve transactions between Centene and its executive officers, directors or their close family members.
Credit rating
Not checked for this page

Flags to know about

  • other

    Securities class action and derivative suits

    A proposed securities class action filed on Jul 9, 2025 in New York alleges that Centene made false and misleading statements about its 2025 earnings guidance. Five related derivative suits allege that directors and officers breached their duties. Centene denies any wrongdoing and says it is defending itself.

  • shares as collateral

    Centene stock as loan collateral

    Centene's policy bars directors and executives from hedging Centene stock, using it as loan collateral or trading derivatives on it.

  • other

    2025 guidance withdrawn

    Centene said in an 8-K filed on Jul 1, 2025 that it withdrew its 2025 GAAP and adjusted EPS guidance, including the elements behind it.

21How it got here

21How it got here

How did Centene get here?

  1. 1984

    Milestone

    First health plan in Wisconsin

    Centene's first health plan started operating in Wisconsin; the company later reincorporated in Delaware in 2001.

  2. 2022

    Business-model change

    New CEO and business sales

    Sarah London became CEO in March 2022, and Centene sold Magellan Rx for $1.3 billion in December 2022.

  3. 2024

    Business-model change

    Back to US health plans

    Centene sold UK hospital group Circle Health for $931 million in January 2024, and its TRICARE military contract ended in December 2024.

  4. 2025

    Crisis

    Guidance withdrawn and a net loss

    Centene withdrew its 2025 earnings guidance on Jul 1, 2025, then recorded a $6.7 billion goodwill impairment in Q3; FY2025 ended with a $6,674 million net loss.

  5. 2026

    Business-model change

    Repricing and job cuts

    Centene repriced Marketplace plans for 2026 and started a voluntary separation program in July 2026; employees fell to 53,900 by Sep 30, 2026.

22Sources and changes

Where every number on this page comes from

Sources (26 documents)
  1. S1Form 10-Q for Q3 FY2026 · SEC EDGAR · Tier 1: company or exchange filing · Oct 27, 2026
  2. S2Form 10-Q for Q2 FY2026 · SEC EDGAR · Tier 1: company or exchange filing · Jul 28, 2026
  3. S3Form 10-Q for Q1 FY2026 · SEC EDGAR · Tier 1: company or exchange filing · Apr 28, 2026
  4. S4Form 10-K for FY2025 · SEC EDGAR · Tier 1: company or exchange filing · Feb 17, 2026
  5. S5Form 10-Q for Q3 FY2025 · SEC EDGAR · Tier 1: company or exchange filing · Oct 29, 2025
  6. S6Form 10-Q for Q2 FY2025 · SEC EDGAR · Tier 1: company or exchange filing · Jul 25, 2025
  7. S7Form 10-Q for Q1 FY2025 · SEC EDGAR · Tier 1: company or exchange filing · Apr 25, 2025
  8. S8Form 10-K for FY2024 · SEC EDGAR · Tier 1: company or exchange filing · Feb 18, 2025
  9. S9Form 10-Q for Q3 FY2024 · SEC EDGAR · Tier 1: company or exchange filing · Oct 25, 2024
  10. S10Form 10-Q for Q2 FY2024 · SEC EDGAR · Tier 1: company or exchange filing · Jul 26, 2024
  11. S11Form 10-Q for Q1 FY2024 · SEC EDGAR · Tier 1: company or exchange filing · Apr 26, 2024
  12. S12Form 10-K for FY2023 · SEC EDGAR · Tier 1: company or exchange filing · Feb 20, 2024
  13. S13Form 10-K for FY2022 · SEC EDGAR · Tier 1: company or exchange filing · Feb 21, 2023
  14. S14Form 10-K for FY2021 · SEC EDGAR · Tier 1: company or exchange filing · Feb 22, 2022
  15. S15Earnings release for Q3 FY2026 (8-K Ex. 99.1) · SEC EDGAR · Tier 1: company or exchange filing · Oct 27, 2026
  16. S16Earnings release for Q2 FY2026 (8-K Ex. 99.1) · SEC EDGAR · Tier 1: company or exchange filing · Jul 28, 2026
  17. S18Earnings release for Q1 FY2026 (8-K Ex. 99.1) · SEC EDGAR · Tier 1: company or exchange filing · Apr 28, 2026
  18. S19Earnings release for Q4 FY2025 (8-K Ex. 99.1) · SEC EDGAR · Tier 1: company or exchange filing · Feb 6, 2026
  19. S20Earnings release for Q3 FY2025 (8-K Ex. 99.1) · SEC EDGAR · Tier 1: company or exchange filing · Oct 29, 2025
  20. S21Earnings release for Q2 FY2025 (8-K Ex. 99.1) · SEC EDGAR · Tier 1: company or exchange filing · Jul 25, 2025
  21. S22Earnings release for Q1 FY2025 (8-K Ex. 99.1) · SEC EDGAR · Tier 1: company or exchange filing · Apr 25, 2025
  22. S23Earnings release for Q4 FY2024 (8-K Ex. 99.1) · SEC EDGAR · Tier 1: company or exchange filing · Feb 4, 2025
  23. S24Earnings release for Q3 FY2024 (8-K Ex. 99.1) · SEC EDGAR · Tier 1: company or exchange filing · Oct 25, 2024
  24. S25Form 8-K filed Jul 1, 2025 (2025 guidance withdrawn) · SEC EDGAR · Tier 1: company or exchange filing · Jul 1, 2025
  25. S27Form 8-K filed Oct 8, 2026 (redemption of 2027 notes) · SEC EDGAR · Tier 1: company or exchange filing · Oct 8, 2026
  26. S31Proxy statement (DEF 14A), 2026 · SEC EDGAR · Tier 1: company or exchange filing · Mar 26, 2026
Changes to this page (v1 · Nov 20, 2026)
  1. v1 · Nov 20, 2026First version. (first version)

Numbers come only from tier 1 and tier 2 sources. Read how we research.

Disclaimer

For learning only. Cityfort is not a registered investment adviser or broker-dealer and does not recommend buying or selling any security. Prices shown are dated and may be out of date.

Investing in securities involves risk, including loss of capital. Before making any investment decision, do your own research and consider consulting a registered investment adviser or other qualified professional.

Cityfort, its owners and contributors may or may not hold securities of companies covered. Cityfort is not paid by any company it covers. Content is not an offer or solicitation to buy or sell any security, including in any initial public offering.

Read the positions policy
Read the full disclaimer

Cityfort publishes general educational content that explains how listed companies work. Cityfort is not registered with the US Securities and Exchange Commission or any state securities regulator as an investment adviser, and is not a broker-dealer or a member of FINRA. Cityfort does not provide investment, tax or legal advice, recommendations, ratings, price targets or any opinion on whether to buy, sell or hold any security. Nothing on the site is tailored to any person's circumstances.

All information is taken from publicly available sources, mainly company filings with the SEC, which are listed on each page with dates. We work to keep it accurate and correct errors publicly, but we do not guarantee that it is complete, accurate or up to date. Any market price or price-based ratio shown is dated, may be out of date by the time you read it, and is included only to explain concepts.

Statements by company management, including forward-looking statements and guidance, are reported as the company's statements, with their date and source; they are not our forecasts. Adjusted (non-GAAP) figures are the company's own measures and are shown next to the official (GAAP) figures.